Health Care Industry

Industry: Email Alert RSS Feed

Kansas Nurse

View more issues:

Articles in Oct 2003 issue of Kansas Nurse

President's pen
by Jones, Janice
personal digital assistant and its future in nursing, The
by Peterson, Moya
CNS or NP debate: The need for a blended advanced practice nursing role
by Grunder, Tamara
Teaching nursing students to teach: Creative Student Instruction
by Bitner, Linda; Giefer, Cheryl; Schiefelbein, Jan; Sheverbush, Joan

Click Here

Most Recent Health Articles

Most Recent Health Publications

Most Popular Health Articles

Most Popular Health Publications

Your Work Vietnam: Opportunity Is Everywhere

Vietnam: Opportunity Is Everywhere

For Westerners with little management experience can have their pick of good jobs in Vietnam.
Your Industry Biogen Corners the Social-Media Market For Its Drugs

Biogen Corners the Social-Media Market For Its Drugs

On November 2, Biogen Idec updated the prescribing label for its blockbuster multiple sclerosis drug Tysabri (natalizumab) after consultation with the FDA. Aside from acknowledging that the risk of developing progressive multifocal leukoencephalopathy (PML), an often fatal brain infection, increases with longer duration of treatment, no other revisions concerning the risk of PML were required. The fact that this biologic remains a cornerstone treatment for adult patients with relapsing forms of MS -- only the second drug to ever return to U.S. pharmacy shelves after having been withdrawn -- speaks volumes to the growing influence of the worldwide web.
Your Money Long-Term-Care Insurance: 4 Biggest Risks to Avoid

Long-Term-Care Insurance: 4 Biggest Risks to Avoid

Recent congressional hearings underscored a host of problems consumers can face with long-term-care insurance. The coverage may still be worthwhile — particularly if stroke or dementia runs in your family — but you should know the risks.